Search Results - Cancer
Suggested Topics within your search.
Suggested Topics within your search.
- Neoplasms 165
- Cancer 150
- therapy 90
- genetics 88
- drug therapy 77
- Antineoplastic Agents 49
- Genetic aspects 49
- immunology 48
- therapeutic use 48
- Treatment 45
- metabolism 42
- Antineoplastic agents 41
- Chemotherapy 41
- methods 41
- Immunotherapy 33
- physiology 31
- prevention & control 28
- diagnosis 26
- pharmacology 26
- Breast Neoplasms 24
- Immunological aspects 23
- complications 23
- Precision Medicine 22
- Signal Transduction 22
- Breast 21
- pathology 20
- Cellular signal transduction 18
- Epigenesis, Genetic 17
- drug effects 17
- Diseases 16
-
1
Viruses and cancer
Published 2007Table of Contents: “…Contents: Oncogenic viruses of animals and humans have given us insights into cancer in general -- Specific genes involved in cancer such as oncogenes and tumor suppressor genes were first discovered through research on tumor viruses -- Only a subset of viruses cause cancer -- For cancers caused by viruses, the viruses are a necessary but insufficient cause of the disease -- Cancer is multifactorial and different risk factors act together -- Vaccines hold great promise to reduce the cancer burden -- The incidence is higher in immunodeficient people -- Transplant recipients and AIDS.…”
Get full text
Series
Electronic Video -
2
Targeting cancer designing drugs against Hsp90 /
Published 2007Table of Contents: “…Contents: Heat shock protein 90 (Hsp90), a target in cancer -- Discovery of the first known Hsp90 inhibitor, geldanamycin -- Use of geldanamycin to understand the role of Hsp90 in malignant transformation -- Discovery of novel Hsp90 inhibitors -- Development and applications of Hsp90 inhibitors.…”
Get full text
Series
Electronic Video -
3
Pancreatic cancer
Published 2011Table of Contents: “…Contents: General epidemiologic data for pancreatic cancer -- Review risk factors for pancreatic cancer -- Clinical presentation and diagnostic modalities for pancreatic cancer -- Current status for early detection, diagnosis and staging of pancreatic cancer -- Treatment of pancreatic cancer.…”
Get full text
Series
Electronic Video -
4
Cancer vaccines part 1 of 2 /
Published 2015Table of Contents: “…Contents: The hallmarks of cancer -- Categories of cancer-associated antigens -- Viral & non-viral cancers: vaccine targets -- Immunotherapeutics -- Immunologic reagents approved for cancer therapy -- Clinical outcome based on immune response -- CTL-based therapy -- Virus-specific CTL adoptive transfer therapy -- Immunotherapy for Melanoma.…”
Get full text
Series (Immunotherapy of cancer)
Series (Vaccines)
Electronic Video -
5
Cancer vaccines part 2 of 2 /
Published 2015Table of Contents: “…Contents: HPV infection & prevention strategies -- Global cervical cancer prevalence -- HPV induced lesions & cancers -- Cell-mediated immune response to HPV -- Synthetic Long Peptide (SLP) vaccine concept -- Vulval intraepithelial neoplasia (VIN) vaccine -- Combining chemotherapy & SLP vaccination.…”
Get full text
Series (Immunotherapy of cancer)
Series (Vaccines)
Electronic Video -
6
Pancreatic cancer
Published 2020Table of Contents: “…Contents: General epidemiologic data for pancreatic cancer -- Review risk factors for pancreatic cancer -- Clinical presentation and diagnostic modalities for pancreatic cancer -- Pancreatic cystic lesions -- Current status for early detection, diagnosis and staging of pancreatic cancer -- Treatment of pancreatic cancer -- Current needs: challenges and opportunities.…”
Get full text
Series
Electronic Video -
7
Ovarian cancer part 1 of 2, molecular characterization /
Published 2019Table of Contents: “…Contents: Introduction to ovarian cancer -- Past therapies for ovarian cancer and their failure -- Heterogeneity in ovarian tumors -- Identification of types of ovarian cancer cells -- Molecular characterization of ovarian cancer cells -- Hierarchy within the ovarian tumors.…”
Get full text
Series
Electronic Video -
8
The biology of cancer
Published 2019Table of Contents: “…Contents: Present general hallmarks of cancer -- Explain how cancer is initiated through activation of oncogenes and deactivation of tumour suppressors -- Highlight what makes these oncogenes and tumour suppressors so special -- Show different ways in which these proteins can modify cell signalling to lead to cancer -- Introduce the notion that cancer is not only about the cancer cell but also about the environment -- Give examples of how we can exploit this combined knowledge to develop cancer therapeutics and the associated challenges.…”
Get full text
Electronic Video -
9
Ovarian cancer progression of tumors /
Published 2019Table of Contents: “…Contents: The origin of ovarian cancer -- Epithelial ovarian cancer cells -- The formation of ovarian tumors -- Luteal cells and ovarian cancer -- The metastatic process in ovarian cancer -- Response to chemotherapy -- The recurrence of cancer stem cells.…”
Get full text
Series
Electronic Video -
10
Cancer immunology
Published 2021Table of Contents: “…Contents: Function and regulation of cell division -- The hallmarks of cancer -- Immune surveillance -- Evidence of anti-tumour T-cell responses -- T cell recognition of cancer cells -- Evasion of tumour immunity -- Immune escape -- Immune suppression.…”
Get full text
Series (Immune system)
Series (Molecular basis of cancer)
Electronic Video -
11
Cancer immunotherapy
Published 2021Subjects: “…Cancer Immunotherapy. 84884…”
Get full text
Series (Immune system)
Series (Molecular basis of cancer)
Electronic Video -
12
Cancer pathology
Published 2020Table of Contents: “…Contents: Cancer pathology -- Histology -- Melanoma -- GI colon cancer -- Breast cancer.…”
Get full text
Series
Electronic Video -
13
Cancer pain
Published 2021Table of Contents: “…Contents: Trends in cancer pain -- Etiology of cancer pain -- Cancer survivors -- Problems faced by cancer survivors who have persistent pain -- Tumor and treatment related pain -- Chronic pain syndromes associated with cancer treatment -- Guidelines for treating cancer survivors who experience persistent pain -- Challenges in managing pain associated with malignancies.…”
Get full text
Series
Electronic Video -
14
Colorectal cancer and hereditary colon cancer syndromes
Published 2011Table of Contents: “…Contents: Colorectal cancer is a molecularly heterogeneous disease known to arise from two distinct origins, the adenomatous and serrated pathways -- Sessile serrated polyps, also known as sessile serrated adenomas, and traditional serrated adenomas are believed to be the precursor lesions for serrated carcinomas which account for up to 30% of sporadic colorectal cancers -- When colorectal polyps or cancer occur in multiple generations, numerous relatives, at a young age of onset or in association with unusual numbers of lesions or extra-colonic tumors, a hereditary colorectal cancer syndrome should be suspected as a potential cause -- The ability to recognize a patient with a hereditary colorectal cancer syndrome allows a practitioner to stratify her or his patient's lifetime cancer risk and devise prevention and management strategies for risk reduction in the patient and family once the diagnosis is confirmed.…”
Get full text
Series
Electronic Video -
15
Targeting the cancer microenvironment inflammatory breast cancer management /
Published 2020Table of Contents: “…Contents: Introduction to inflammatory breast cancer -- Epidemiology of IBC -- Approaches to treatment of IBC -- Molecular analysis of IBC -- The contribution of microenvironmental factors to the aggressiveness of IBC -- Targeting the cancer microenvironmental factors for treating IBC -- The involvement of macrophages and mast cells in the aggressiveness of IBC.…”
Get full text
Electronic Video -
16
RNA interference and cancer a revolution? /
Published 2007Table of Contents: “…Contents: Cancer overview -- RNA interference to understand cancer -- Natural short RNAs in cancer -- RNA interference to fight cancer.…”
Get full text
Series
Electronic Video -
17
Cancer pain control an evidence-based approach /
Published 2021Table of Contents: “…Contents: Importance of cancer pain control -- Assessment and sources of cancer pain -- Selecting agents according to pain mechanism -- The WHO ladder -- Nonopioids and adjuvants -- Opioids -- Side effects -- Neuraxial drug delivery -- Nondrug modalities -- What does the published evidence show?.…”
Get full text
Series
Electronic Video -
18
Principles of cancer treatment surgery, radiotherapy, chemotherapy, immunotherapy /
Published 2009Table of Contents: “…Contents: Historic principles leading to modern cancer treatments -- Specific reviews of surgery, radiotherapy, chemotherapy, hormone therapy and immunotherapy development -- Significant developments in present use -- Modern concepts using combined modality approaches -- Latest technological developments in radiotherapy -- Latest developments and implementation of immunotherapy -- Discussion of near future events and possibilities.…”
Get full text
Series
Electronic Video -
19
Understanding cancer trends
Published 2009Table of Contents: “…Contents: Current trends in cancer incidence, mortality and relative survival in the US -- Understanding how improvements in prevention, early detection and treatment affect these trends -- How demographic changes affect the number of cancer cases and deaths but not the age-standardized incidence or death rates -- Specific cancer sites for which the incidence and/or death rates are changing -- Role of prevention, early detection, and improvements in treatment in reducing the burden of cancer.…”
Get full text
Series
Electronic Video -
20
Therapy in cancer 2008 quo vadis? /
Published 2009Table of Contents: “…Contents: Why pursuing new therapeutic approaches in cancer is important -- Prevention and screening -- Current cancer therapy: non-surgical -- Most chemotherapy targets DNA -- Chemotherapy effects -- Current state of cancer therapy: efficacy and toxicity -- Molecular pathogenesis of cancer -- Pursuing targeted therapy in cancers -- Targeted biologic therapies -- Evolving targets and agents -- Shift from chemotherapy to targeted agents -- Clinically established molecular targets in malignancies -- Targeted therapy: proteins and small molecules -- Changes brought about by targeting: efficacy and toxicity -- Biomarkers in drug development -- What is currently known: angiogenesis -- The VEGF family and its receptors -- Bevacizumab and Sorafenib -- Does toxicity correlate with response? …”
Get full text
Series
Electronic Video